PAPER Okun E, Griffioen KJ, Mattson MP
SEARCH RESULTS
331009 RESULTS
PAPER Abe N, Fujii T, Nishio Y, Iizuka O, Kanno S, Kikuchi H, Takagi M, Hiraoka K, Yamasaki H, Choi H, Hirayama K, Shinohara M, Mori E
False item recognition in patients with Alzheimer's disease.
Neuropsychologia. 2011 Jun;49(7):1897-902. PubMed: 21419789PAPER Shiradkar M, Thomas J, Kanase V, Dighe R
Studying synergism of methyl linked cyclohexyl thiophenes with triazole: synthesis and their cdk5/p25 inhibition activity.
Eur J Med Chem. 2011 Jun;46(6):2066-74. PubMed: 21420204PAPER González-Muñoz GC, Arce MP, López B, Pérez C, Romero A, Del Barrio L, Martín-de-Saavedra MD, Egea J, León R, Villarroya M, López MG, García AG, Conde S, Rodríguez-Franco MI
N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
Eur J Med Chem. 2011 Jun;46(6):2224-35. PubMed: 21420206PAPER Getsios D, Blume S, Ishak KJ, Maclaine G, Hernández L
An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom.
Alzheimers Dement. 2011 Mar 21; PubMed: 21420366PAPER Eschbach J, Dupuis L
Cytoplasmic dynein in neurodegeneration.
Pharmacol Ther. 2011 Jun;130(3):348-63. PubMed: 21420428PAPER Koric L, Felician O, Ceccaldi M
[Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice].
Rev Neurol (Paris). 2011 Jun-Jul;167(6-7):474-84. PubMed: 21420704PAPER Vincent B, Govitrapong P
Activation of the α-secretase processing of AβPP as a therapeutic approach in Alzheimer's disease.
J Alzheimers Dis. 2011;24 Suppl 2:75-94. PubMed: 21422515PAPER Barten DM, Cadelina GW, Hoque N, Decarr LB, Guss VL, Yang L, Sankaranarayanan S, Wes PD, Flynn ME, Meredith JE, Ahlijanian MK, Albright CF
Tau transgenic mice as models for cerebrospinal fluid tau biomarkers.
J Alzheimers Dis. 2011;24 Suppl 2:127-41. PubMed: 21422517PAPER Britton GB, Rao KS
Cognitive aging and early diagnosis challenges in Alzheimer's disease.
J Alzheimers Dis. 2011;24 Suppl 2:153-9. PubMed: 21422518PAPER Gallo M, Marcello N, Curcio SA, Colao R, Geracitano S, Bernardi L, Anfossi M, Puccio G, Frangipane F, Clodomiro A, Mirabelli M, Vasso F, Smirne N, Muraca G, Di Lorenzo R, Maletta R, Ghidoni E, Bugiani O, Tagliavini F, Giaccone G, Bruni AC
A novel pathogenic PSEN1 mutation in a family with Alzheimer's disease: phenotypical and neuropathological features.
J Alzheimers Dis. 2011;25(3):425-31. PubMed: 21422519PAPER Cao C, Wang L, Lin X, Mamcarz M, Zhang C, Bai G, Nong J, Sussman S, Arendash G
Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice.
J Alzheimers Dis. 2011;25(2):323-35. PubMed: 21422521PAPER Schürmann B, Wiese B, Bickel H, Weyerer S, Riedel-Heller SG, Pentzek M, Bachmann C, Williams J, van den Bussche H, Maier W, Jessen F
Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration.
J Alzheimers Dis. 2011;25(3):421-4. PubMed: 21422520PAPER Derflinger S, Sorg C, Gaser C, Myers N, Arsic M, Kurz A, Zimmer C, Wohlschläger A, Mühlau M
Grey-matter atrophy in Alzheimer's disease is asymmetric but not lateralized.
J Alzheimers Dis. 2011;25(2):347-57. PubMed: 21422522PAPER Neufang S, Akhrif A, Riedl V, Förstl H, Kurz A, Zimmer C, Sorg C, Wohlschläger AM
Disconnection of frontal and parietal areas contributes to impaired attention in very early Alzheimer's disease.
J Alzheimers Dis. 2011;25(2):309-21. PubMed: 21422523Current Filters
No filters selected